These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 8425750)
1. A model for metastases formation. Markovitch S Int J Biomed Comput; 1993 Jan; 32(1):19-33. PubMed ID: 8425750 [TBL] [Abstract][Full Text] [Related]
2. A mathematical model of drug resistance: heterogeneous tumors. Panetta JC Math Biosci; 1998 Jan; 147(1):41-61. PubMed ID: 9401351 [TBL] [Abstract][Full Text] [Related]
3. Critical determinants of metastasis. Fidler IJ Semin Cancer Biol; 2002 Apr; 12(2):89-96. PubMed ID: 12027580 [TBL] [Abstract][Full Text] [Related]
4. A mathematical model of periodically pulsed chemotherapy: tumor recurrence and metastasis in a competitive environment. Panetta JC Bull Math Biol; 1996 May; 58(3):425-47. PubMed ID: 8688836 [TBL] [Abstract][Full Text] [Related]
5. Experimental chemotherapy and concepts related to the cell cycle. Tannock IF Int J Radiat Biol Relat Stud Phys Chem Med; 1986 Feb; 49(2):335-55. PubMed ID: 3510996 [TBL] [Abstract][Full Text] [Related]
7. A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate. Goldie JH; Coldman AJ Cancer Treat Rep; 1979; 63(11-12):1727-33. PubMed ID: 526911 [TBL] [Abstract][Full Text] [Related]
8. The challenge of targeting metastasis. Fidler IJ; Kripke ML Cancer Metastasis Rev; 2015 Dec; 34(4):635-41. PubMed ID: 26328524 [TBL] [Abstract][Full Text] [Related]
10. Recent observations on the pathogenesis of cancer metastasis. Fidler IJ; Hart IR Prog Clin Biol Res; 1982; 85 Pt B():601-19. PubMed ID: 6750636 [No Abstract] [Full Text] [Related]
11. Cancer therapy: an evolved approach. Willyard C Nature; 2016 Apr; 532(7598):166-8. PubMed ID: 27075079 [No Abstract] [Full Text] [Related]
12. Concepts for the treatment of tumor metastasis. Griswold DP; Schabel FM; Dykes DJ; Trader MW; Laster WR Symp Fundam Cancer Res; 1983; 36():389-96. PubMed ID: 6382515 [No Abstract] [Full Text] [Related]
13. An integrated cellular and sub-cellular model of cancer chemotherapy and therapies that target cell survival. Cook AB; Ziazadeh DR; Lu J; Jackson TL Math Biosci Eng; 2015 Dec; 12(6):1219-35. PubMed ID: 26775858 [TBL] [Abstract][Full Text] [Related]
15. Heterogeneity in growth pattern and drug sensitivity of primary tumor and metastases in the human tumor colony-forming assay. Schlag P; Schreml W Cancer Res; 1982 Oct; 42(10):4086-9. PubMed ID: 7105006 [TBL] [Abstract][Full Text] [Related]
16. Anti-metastatics: an overview of drug candidates in current pipelines. Schaap-Nutt A; Thyssen DA; Drell DW; Entschladen F Curr Pharm Des; 2014; 20(42):6522-8. PubMed ID: 25341929 [TBL] [Abstract][Full Text] [Related]
17. Metastasis and the Tumor Microenvironment: A Joint Metastasis Research Society-AACR Conference - Research on Metastasis: Part 1. Eccles SA IDrugs; 2010 Nov; 13(11):765-7. PubMed ID: 21046522 [TBL] [Abstract][Full Text] [Related]
18. Mechanisms of development of metastases. Plesnicar S Crit Rev Oncog; 1989; 1(2):175-94. PubMed ID: 2488129 [No Abstract] [Full Text] [Related]
20. Chemotherapeutic treatments involving drug resistance and level of normal cells as a criterion of toxicity. Costa MI; Boldrini JL; Bassanezi RC Math Biosci; 1995 Feb; 125(2):211-28. PubMed ID: 7881195 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]